Agrematch
Agrematch is an AI-driven R&D platform that helps enterprise chemistry teams in agriculture, food, specialty chemicals, personal care, and animal health accelerate discovery through predictive modeling, de novo molecule generation, and formulation intelligence.
- Company typePrivate
- Founded2020
- HeadquartersRehovot, Israel
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Agrematch does
Agrematch is an AI-driven R&D acceleration platform focused on function-first chemistry for enterprise R&D teams across agriculture, food and nutrition, specialty chemicals and materials, personal care and cosmetics, animal health and feed, and small-molecule discovery. The company's core offering is a five-module platform — Compound Predictor, Compound Analyzer, Library Analyzer, Compound Designer, and Chart Board — that combines proprietary chemistry data, predictive models, and expert workflows to evaluate compound activity, safety, toxicity, manufacturability, formulation fit, mix performance, environmental profile, and cost earlier in the discovery process. Agrematch also provides formulation intelligence, historical data activation (turning archived experimental data into searchable predictive infrastructure), and workflow integration that embeds AI into existing R&D processes. The platform generates and evaluates de novo molecules around defined functional goals, with Ruby (a patent-pending, computationally designed natural weed-control molecule) serving as a representative output. Agrematch operates a consultative enterprise sales motion through a 'Let's Talk' / 'Challenge us' contact form, engaging R&D teams on specific chemistry challenges via strategic R&D partnerships. Named customers include Qemetica, Adama, Nichino, ICL Group (also a strategic investor), Thrive Algorithmic Intelligence, and SVG Ventures. The company was founded in 2017, is headquartered in Rehovot, Israel, employs 11–50 people, and has raised funding from Ocean Azul Partners and ICL Planet Startup Hub across rounds in 2018, 2020, and 2023. The advisory board includes two Nobel laureates (Prof. Michael Levitt, Prof. Aaron Ciechanover) and senior executives from Monsanto, Syngenta, Corteva, ADAMA, and Pairwise.
Agrematch firmographics
Firmographics- Name
- Agrematch
- Legal name
- Agrematch
- Website
- https://agrematch.com
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Agrematch is an AI-driven R&D platform that helps enterprise chemistry teams in agriculture, food, specialty chemicals, personal care, and animal health accelerate discovery through predictive modeling, de novo molecule generation, and formulation intelligence.
- Ownership category
- akta.pro rank
Agrematch industry classification
Industry- Product category
- AI-powered chemistry R&D software
- NAICS
- Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- AI/ML Platforms for Drug Discovery & Experiment Optimization (HLAGAJAO)
- akta.pro secondary industries
- Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D) (HLAGAJAC), Crop Protection Formulations (EC, SC, WG, WP, SL) (AFABAIAA)
Keywords
Where Agrematch is headquartered
LocationHeadquarters
- HQ city
- Rehovot
- HQ country
- Israel
- HQ region
- Middle East
Markets served
Agrematch business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Revenue model
- Enterprise AI R&D Services: Agrematch operates as an applied AI R&D acceleration partner for industrial chemistry and biology. The company helps R&D teams use historical experimental knowledge, predictive modeling, and formulation intelligence. Revenue appears to come from strategic R&D partnerships and consulting-style engagements where Agrematch works alongside enterprise R&D teams on specific chemistry challenges.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
Agrematch product offering
Product offeringCore offering
Agrematch provides an AI-powered R&D acceleration platform for enterprise chemistry and biology teams. The platform combines proprietary chemistry data, predictive models, and expert workflows to help R&D teams evaluate compound options earlier, generate de novo molecules, predict formulations, and turn archived experimental data into AI-ready intelligence. Deliverables span discovery, formulation, predictive modeling, custom workflows, and AI-ready data, targeted at enterprise R&D teams in agriculture, food, specialty chemicals, personal care, and animal health.
Product overview
Agrematch is an AI-powered R&D acceleration platform for industrial chemistry and biology. The platform consists of five core technology modules: Compound Predictor (for predictive assessment of compound properties), Compound Analyzer (for comparing chemistry options), Library Analyzer (for evaluating and prioritizing compound libraries at scale), Compound Designer (for generating and evaluating de novo molecules), and Chart Board (for organizing and presenting discovery insights). These modules work together to help enterprise R&D teams turn chemistry goals into stronger decisions across discovery, active mixes, formulations, predictive modeling, custom workflows, and AI-ready data. The platform also provides formulation intelligence, historical data activation, and workflow integration services.
Differentiator
Problem solved
Functional benefit
Brands
- Ruby: A representative molecule from Agrematch's natural weed-control pipeline, computationally generated and optimized beyond traditional screening to deliver validated weed-control chemistry with commercial development potential.
Products and services
- Compound Predictor Predicts and assesses compound properties such as activity, safety, toxicity, manufacturability, formulation fit, mix performance, environmental profile, and cost earlier in the R&D process for enterprise chemistry teams.
- Compound Analyzer Compares individual compounds and chemistry options through a decision lens, enabling R&D teams to evaluate and rank candidates against multiple criteria.
- Library Analyzer Evaluates compound libraries at scale and turns large chemistry sets into clearer shortlists, enabling high-throughput prioritization of candidates for enterprise R&D teams.
- Compound Designer Generates and evaluates de novo molecules around defined functional goals and application requirements, computationally creating and optimizing novel compounds beyond traditional screening.
- Chart Board Organizes, analyzes, and presents discovery insights during customer projects through tailored dashboards for tracking and communicating R&D decisions and outcomes.
- Ruby Natural Weed-Control Molecule A representative patent-pending molecule from Agrematch's natural weed-control pipeline, computationally generated and optimized beyond traditional screening to deliver validated weed-control chemistry with commercial development potential.
Quantifiable outcome
- More than 60% of new chemical product launches fail according to EY-Parthenon research; Agrematch aims to reduce this by enabling earlier identification of weak candidates and development risks.
Companies that use Agrematch
Customer profileNamed customers6 records
Segments6 records
Ideal customer profiles6 records
Agrematch technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability5 records
Feature8 records
Agrematch partnerships and signals
Strategic signalRecent moves6 records
Expansion highlights5 records
Agrematch competitors and assessment
Company assessmentBroad incumbents
- Recursion: Recursion is an AI-driven drug discovery company combining high-throughput biology with machine learning. It shares the AI-for-discovery DNA with Agrematch but operates at significantly larger scale and is concentrated in pharma rather than industrial chemistry.
- Insitro: Insitro applies machine learning to drug discovery and development, combining predictive models with experimental data. It is a broad incumbent peer in the AI-for-R&D category, comparable in approach (predictive + data-driven discovery) though focused on therapeutics.
Emerging players
- Kebotix: Kebotix is an AI-driven materials discovery company focused on specialty chemicals and sustainable materials. It is comparable to Agrematch's specialty chemicals and PFAS alternative use cases, with a similar horizontal R&D acceleration approach.
- Benchling: Benchling provides a cloud R&D data platform for life sciences, including chemistry and biology workflows. It overlaps with Agrematch's historical data activation and workflow integration capabilities, although Benchling focuses more on data infrastructure than predictive molecule design.
- Cradle: Cradle uses generative AI to design proteins and biological molecules for biotech R&D. It overlaps with Agrematch's generative Compound Designer capability, though Cradle is focused on biologics rather than small-molecule industrial chemistry.
Direct peers
- Citrine Informatics: Citrine Informatics applies AI to materials and chemicals R&D, helping enterprise teams accelerate discovery and formulation. It is highly comparable to Agrematch's materials, formulation, and specialty chemicals focus, with an overlapping horizontal platform strategy.
- Schrödinger: Schrödinger provides physics-based and AI-driven molecular simulation software for drug discovery and materials science. It is the closest direct peer to Agrematch's Compound Predictor and Compound Designer modules, though Schrödinger is more established in pharma while Agrematch focuses on agrochemical and specialty chemistry R&D.
- Atomwise: Atomwise uses AI for small-molecule design and discovery, primarily in pharma and increasingly in agriculture and animal health. It is directly comparable to Agrematch's Compound Designer and predictive modeling capabilities, particularly for crop protection R&D.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Agrematch social profiles
Digital presenceAgrematch financial estimates
Financial estimateRevenue estimate
Valuation estimate
Agrematch leadership team
Management profileNumber of profiles
Profiles14 records
Agrematch funding detail
Funding detailFunding overview
Funding rounds3 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Agrematch M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Agrematch
What does Agrematch do?
Agrematch provides an AI-powered R&D acceleration platform for enterprise chemistry and biology teams. The platform combines proprietary chemistry data, predictive models, and expert workflows to help R&D teams evaluate compound options earlier, generate de novo molecules, predict formulations, and turn archived experimental data into AI-ready intelligence. Deliverables span discovery, formulation, predictive modeling, custom workflows, and AI-ready data, targeted at enterprise R&D teams in agriculture, food, specialty chemicals, personal care, and animal health.
Is Agrematch a public or private company?
Agrematch is a private company. It is classified as venture growth investor backed and is currently operating.
When was Agrematch founded?
Agrematch was founded in 2020. It employs 11 to 50 people.
Where is Agrematch based?
Agrematch is headquartered in Rehovot, Israel, in the Middle East region.
How does Agrematch make money?
One revenue line is on record: enterprise AI R&D Services.
Who are Agrematch's main competitors?
Broad incumbents on record are Recursion and Insitro. Emerging players are Kebotix, Benchling and Cradle. Direct peers are Citrine Informatics, Schrödinger and Atomwise.
Does Agrematch have an API?
No public API is recorded for Agrematch.
What industry is Agrematch in?
Agrematch's product category is AI-powered chemistry R&D software. Its primary akta.pro industry code is HLAGAJAO, AI/ML Platforms for Drug Discovery & Experiment Optimization, with a secondary code of HLAGAJAC, Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D). Its NAICS code is 5417 and its SIC code is 7372.